1. Home
  2. CVKD vs MOBX Comparison

CVKD vs MOBX Comparison

Compare CVKD & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • MOBX
  • Stock Information
  • Founded
  • CVKD 2022
  • MOBX 2020
  • Country
  • CVKD United States
  • MOBX United States
  • Employees
  • CVKD N/A
  • MOBX N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • MOBX
  • Sector
  • CVKD Health Care
  • MOBX
  • Exchange
  • CVKD Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • CVKD 29.5M
  • MOBX 34.2M
  • IPO Year
  • CVKD 2023
  • MOBX N/A
  • Fundamental
  • Price
  • CVKD $12.71
  • MOBX $0.85
  • Analyst Decision
  • CVKD Strong Buy
  • MOBX
  • Analyst Count
  • CVKD 1
  • MOBX 0
  • Target Price
  • CVKD $32.00
  • MOBX N/A
  • AVG Volume (30 Days)
  • CVKD 36.2K
  • MOBX 245.3K
  • Earning Date
  • CVKD 08-06-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • CVKD N/A
  • MOBX N/A
  • EPS Growth
  • CVKD N/A
  • MOBX N/A
  • EPS
  • CVKD N/A
  • MOBX N/A
  • Revenue
  • CVKD N/A
  • MOBX $10,692,000.00
  • Revenue This Year
  • CVKD N/A
  • MOBX N/A
  • Revenue Next Year
  • CVKD N/A
  • MOBX N/A
  • P/E Ratio
  • CVKD N/A
  • MOBX N/A
  • Revenue Growth
  • CVKD N/A
  • MOBX 450.28
  • 52 Week Low
  • CVKD $5.70
  • MOBX $0.55
  • 52 Week High
  • CVKD $22.90
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.98
  • MOBX 64.11
  • Support Level
  • CVKD $11.00
  • MOBX $0.72
  • Resistance Level
  • CVKD $13.56
  • MOBX $0.84
  • Average True Range (ATR)
  • CVKD 1.15
  • MOBX 0.06
  • MACD
  • CVKD 0.25
  • MOBX 0.01
  • Stochastic Oscillator
  • CVKD 80.97
  • MOBX 89.32

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: